| pubmed-article:15904651 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0054015 | lld:lifeskim |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0199548 | lld:lifeskim |
| pubmed-article:15904651 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:15904651 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:15904651 | pubmed:dateCreated | 2005-5-20 | lld:pubmed |
| pubmed-article:15904651 | pubmed:abstractText | After successful external cardioversion, the rate of recurrence of atrial fibrillation remains high. The hypothesis that plasma B-type natriuretic peptide could predict the recurrence of atrial fibrillation at 1 year was tested. Plasma B-type natriuretic peptide was measured in 66 consecutive asymptomatic patients who underwent external cardioversion for atrial fibrillation. Twelve-lead electrocardiograms were obtained at 1 year. Sinus rhythm was maintained in 55% of patients. The independent predictors of the recurrence of atrial fibrillation at 1 year were a history of atrial fibrillation, plasma B-type natriuretic peptide, and the energy delivered for conversion. In patients without symptoms of heart failure, plasma B-type natriuretic peptide is an independent predictor of the recurrence of atrial fibrillation. | lld:pubmed |
| pubmed-article:15904651 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15904651 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15904651 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15904651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15904651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15904651 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15904651 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15904651 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:GarotJérômeJ | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:GuéretPascalP | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:Mekontso-Dess... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:Dubois-RandéJ... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:MoninJean-Luc... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:BraconnierFra... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:LelloucheNico... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:DuvalAnne-Mar... | lld:pubmed |
| pubmed-article:15904651 | pubmed:author | pubmed-author:BerthierRomai... | lld:pubmed |
| pubmed-article:15904651 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15904651 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15904651 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:15904651 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15904651 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15904651 | pubmed:pagination | 1380-2 | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:meshHeading | pubmed-meshheading:15904651... | lld:pubmed |
| pubmed-article:15904651 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15904651 | pubmed:articleTitle | Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. | lld:pubmed |
| pubmed-article:15904651 | pubmed:affiliation | Fédération de Cardiologie, Hôpital de Jour, Henri Mondor University Hospital, Créteil, France. | lld:pubmed |
| pubmed-article:15904651 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15904651 | lld:pubmed |
